Cargando…

Comparative Global Epidemiological Investigation of SARS-CoV-2 and SARS-CoV Diseases Using Meta-MUMS Tool Through Incidence, Mortality, and Recovery Rates

COVID-19 is a novel coronavirus that was reported by the world health organization in late December 2019. As an unexplained respiratory disease epidemic, which is similar to respiratory syndrome coronavirus SARS-CoV, it rapidly spread all over the world. The study aims to compare several parameters...

Descripción completa

Detalles Bibliográficos
Autores principales: Sokouti, Massoud, Sadeghi, Ramin, Pashazadeh, Saeid, Eslami, Saeid, Sokouti, Mohsen, Ghojazadeh, Morteza, Sokouti, Babak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IMSS. Published by Elsevier Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158781/
https://www.ncbi.nlm.nih.gov/pubmed/32331787
http://dx.doi.org/10.1016/j.arcmed.2020.04.005
_version_ 1783522553325682688
author Sokouti, Massoud
Sadeghi, Ramin
Pashazadeh, Saeid
Eslami, Saeid
Sokouti, Mohsen
Ghojazadeh, Morteza
Sokouti, Babak
author_facet Sokouti, Massoud
Sadeghi, Ramin
Pashazadeh, Saeid
Eslami, Saeid
Sokouti, Mohsen
Ghojazadeh, Morteza
Sokouti, Babak
author_sort Sokouti, Massoud
collection PubMed
description COVID-19 is a novel coronavirus that was reported by the world health organization in late December 2019. As an unexplained respiratory disease epidemic, which is similar to respiratory syndrome coronavirus SARS-CoV, it rapidly spread all over the world. The study aims to compare several parameters of COVID-19 and SARS-CoV infectious diseases in terms of incidence, mortality, and recovery rates. The publicly available dataset Worldometer (extracted on April 5, 2020) confirmed by WHO report was available for meta-analysis purposes using the Meta-MUMS tool. And, the reported outcomes of the analysis used a random-effects model to evaluate the event rate, and risk ratios thorough subgroup analysis forest plots. Seventeen countries for COVID-19 and eight countries of SARS infections, including COVID-19 group n = 1124243, and SARS-CoV group n = 8346, were analyzed. In this meta-analysis, a random effect model of relations of incidence, mortality, and recovery rates of COVID-19 and SARS world infections were determined. The meta-analysis and forest plots of two viral world infections showed that the incidence rate of COVID-19 infection is more than SARS infections, while recovery and mortality event rates of SARS-CoV are more than COVID-19 infection. And subgroup analysis showed that the mortality and recovery rates were higher in both SARS-CoV wand COVID-19 in comparison to incidence and mortality rates, respectively. In conclusion, the meta-analysis approach on the abovementioned dataset revealed the epidemiological and statistical analyses for comparing COVID-19 and SARS-CoV outbreaks.
format Online
Article
Text
id pubmed-7158781
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher IMSS. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71587812020-04-15 Comparative Global Epidemiological Investigation of SARS-CoV-2 and SARS-CoV Diseases Using Meta-MUMS Tool Through Incidence, Mortality, and Recovery Rates Sokouti, Massoud Sadeghi, Ramin Pashazadeh, Saeid Eslami, Saeid Sokouti, Mohsen Ghojazadeh, Morteza Sokouti, Babak Arch Med Res Article COVID-19 is a novel coronavirus that was reported by the world health organization in late December 2019. As an unexplained respiratory disease epidemic, which is similar to respiratory syndrome coronavirus SARS-CoV, it rapidly spread all over the world. The study aims to compare several parameters of COVID-19 and SARS-CoV infectious diseases in terms of incidence, mortality, and recovery rates. The publicly available dataset Worldometer (extracted on April 5, 2020) confirmed by WHO report was available for meta-analysis purposes using the Meta-MUMS tool. And, the reported outcomes of the analysis used a random-effects model to evaluate the event rate, and risk ratios thorough subgroup analysis forest plots. Seventeen countries for COVID-19 and eight countries of SARS infections, including COVID-19 group n = 1124243, and SARS-CoV group n = 8346, were analyzed. In this meta-analysis, a random effect model of relations of incidence, mortality, and recovery rates of COVID-19 and SARS world infections were determined. The meta-analysis and forest plots of two viral world infections showed that the incidence rate of COVID-19 infection is more than SARS infections, while recovery and mortality event rates of SARS-CoV are more than COVID-19 infection. And subgroup analysis showed that the mortality and recovery rates were higher in both SARS-CoV wand COVID-19 in comparison to incidence and mortality rates, respectively. In conclusion, the meta-analysis approach on the abovementioned dataset revealed the epidemiological and statistical analyses for comparing COVID-19 and SARS-CoV outbreaks. IMSS. Published by Elsevier Inc. 2020-07 2020-04-15 /pmc/articles/PMC7158781/ /pubmed/32331787 http://dx.doi.org/10.1016/j.arcmed.2020.04.005 Text en © 2020 IMSS. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Sokouti, Massoud
Sadeghi, Ramin
Pashazadeh, Saeid
Eslami, Saeid
Sokouti, Mohsen
Ghojazadeh, Morteza
Sokouti, Babak
Comparative Global Epidemiological Investigation of SARS-CoV-2 and SARS-CoV Diseases Using Meta-MUMS Tool Through Incidence, Mortality, and Recovery Rates
title Comparative Global Epidemiological Investigation of SARS-CoV-2 and SARS-CoV Diseases Using Meta-MUMS Tool Through Incidence, Mortality, and Recovery Rates
title_full Comparative Global Epidemiological Investigation of SARS-CoV-2 and SARS-CoV Diseases Using Meta-MUMS Tool Through Incidence, Mortality, and Recovery Rates
title_fullStr Comparative Global Epidemiological Investigation of SARS-CoV-2 and SARS-CoV Diseases Using Meta-MUMS Tool Through Incidence, Mortality, and Recovery Rates
title_full_unstemmed Comparative Global Epidemiological Investigation of SARS-CoV-2 and SARS-CoV Diseases Using Meta-MUMS Tool Through Incidence, Mortality, and Recovery Rates
title_short Comparative Global Epidemiological Investigation of SARS-CoV-2 and SARS-CoV Diseases Using Meta-MUMS Tool Through Incidence, Mortality, and Recovery Rates
title_sort comparative global epidemiological investigation of sars-cov-2 and sars-cov diseases using meta-mums tool through incidence, mortality, and recovery rates
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158781/
https://www.ncbi.nlm.nih.gov/pubmed/32331787
http://dx.doi.org/10.1016/j.arcmed.2020.04.005
work_keys_str_mv AT sokoutimassoud comparativeglobalepidemiologicalinvestigationofsarscov2andsarscovdiseasesusingmetamumstoolthroughincidencemortalityandrecoveryrates
AT sadeghiramin comparativeglobalepidemiologicalinvestigationofsarscov2andsarscovdiseasesusingmetamumstoolthroughincidencemortalityandrecoveryrates
AT pashazadehsaeid comparativeglobalepidemiologicalinvestigationofsarscov2andsarscovdiseasesusingmetamumstoolthroughincidencemortalityandrecoveryrates
AT eslamisaeid comparativeglobalepidemiologicalinvestigationofsarscov2andsarscovdiseasesusingmetamumstoolthroughincidencemortalityandrecoveryrates
AT sokoutimohsen comparativeglobalepidemiologicalinvestigationofsarscov2andsarscovdiseasesusingmetamumstoolthroughincidencemortalityandrecoveryrates
AT ghojazadehmorteza comparativeglobalepidemiologicalinvestigationofsarscov2andsarscovdiseasesusingmetamumstoolthroughincidencemortalityandrecoveryrates
AT sokoutibabak comparativeglobalepidemiologicalinvestigationofsarscov2andsarscovdiseasesusingmetamumstoolthroughincidencemortalityandrecoveryrates